Pharsight Launches PKS Online™, Bringing Benefits Of Leading PK Data Management Solution To Customers On-Demand
Internet-Accessible Version of Pharsight Knowledgebase Server Enables Productivity and Compliance Benefits in Cost Efficient, Scalable Offering
Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced the launch of PKS Online™. PKS Online is an Internet-accessible implementation of Pharsight Knowledgebase Server™ (PKS™), the company's enterprise data management system for secure storage and tracking of PK/PD data and analyses, that lets customers realize the benefits of a compliant PK repository without upfront capital expenditure.
"PKS Online offers the full benefits and value of PKS to drug development organizations with limited staff and resources for deployment, validation and management of an in-house system," said Daniel Weiner, Ph.D., senior vice president and chief technology officer of Pharsight. "PKS Online provides secure storage, access and tracking for PK/PD data, analyses and related files, all of which are accessible over the Internet from networked desktops. Like PKS, PKS Online remains fully integrated with Phoenix™ WinNonlin®, Phoenix Connect™ and earlier versions of WinNonlin®, as well as Pharsight's software tools for PK analysis automation and reporting. The result is improved productivity and compliance for PK scientists, data managers, quality assurance experts and their company's external development partners and collaborators."
PKS Online is offered on a subscription basis, with flexible licensing and valueadded validation support services. Pharsight has engaged with Savvis, a global leader in outsourced internet infrastructure services for the enterprise, to deliver PKS Online.
"The release of PKS Online demonstrates Pharsight's ongoing commitment to providing our customers with access to software solutions that enable modelbased drug development and its utility in translational science," added Dr. Weiner. "With PKS Online, we are extremely pleased to deliver the benefits of PKS to a wider range of pharmaceutical and biotechnology industry customers through a software-as-a-service model, and look forward to moving them into production quickly and reliably to meet their drug development objectives."
About PKS Online™
PKS Online is an Internet-accessible implementation of Pharsight
Knowledgebase Server™ (PKS), the company's enterprise data management
system for secure storage and tracking of PK/PD data and analyses. Pharsight
has engaged with a leading hosting provider to bring the benefits of PKS to
scientist's desktops on-demand. Using a standard desktop computer and a
standard network connection, PK scientists, data managers, review staff and a
sponsor's external development partners can access PKS Online through a
secure channel from virtually anywhere and at anytime. Pharsight believes that
the availability of a comprehensive and accessible PK/PD research data
management system will provide a foundation for a more rational and costeffective
drug development process, by improving scientific productivity and
compliance and dramatically reducing IT overhead. More information about PKS
Online is available at www.pharsight.com.
About Pharsight
Pharsight, a Certara™ company, is a market-leading provider of software
products and scientific consulting services to help pharmaceutical and
biotechnology companies improve their drug development process, regulatory
compliance and strategic decision-making. Established in 1995, the company's
goal is to help customers reduce the time, cost and risk of drug development, as
well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight leverages expertise in its software tools and in the disciplines of
pharmacology, drug and disease modeling, human genetics, biostatistics,
strategic decision-making and regulatory strategy. Headquartered in St. Louis,
Missouri, with more than 1200 customers worldwide, Pharsight products and
services are used by all of the world's top 50 pharmaceutical firms.
About Certara
Certara is dedicated to improving human health through a broad spectrum of
products and services, from molecular discovery to clinical research. Formed in
2008, Certara unites Tripos and Pharsight Corporation. Tripos is a global leader
in innovative scientific solutions enabling life science researchers to improve the
efficiency of molecular discovery. Pharsight is the leading provider of software
and scientific services to improve productivity and decision-making in clinical
drug development. Certara expects to provide its clients with important new
products, key enabling technologies and scientific expertise to expedite the flow
of information throughout drug discovery and development. Certara is focused
on reducing the barriers between the phases of research that will speed
discoveries in chemistry and enable pharmaceutical and biotechnology
companies to achieve significant and enduring improvements in the development
and use of therapeutic products.
SOURCE: Pharsight